Literature DB >> 15262188

Homocysteine and carotid atherosclerosis in chronic renal failure--the confounding effect of renal function.

Yrjö Leskinen1, Terho Lehtimäki, Antti Loimaala, Heini Huhtala, Juha P Salenius, Simo S Oja, Heikki Saha.   

Abstract

Since total homocysteine (tHcy) level is markedly elevated in patients with chronic renal failure (CRF), it has been presented as a potential factor contributing to the high risk of cardiovascular disease (CVD) in CRF. Our aim was to examine the significance of elevated tHcy level and other cardiovascular risk factors for carotid atherosclerosis in patients with CRF. In this cross-sectional study, 135 study patients with CRF (52 +/- 11 years) included 58 patients with moderate to severe predialysis CRF, 36 dialysis patients and 41 renal transplant recipients. In addition, 58 control subjects were examined. The association of tHcy level and classic risk factors for atherosclerosis with common carotid artery intima-media thickness (IMT) or carotid artery plaque score was examined. We found no association between tHcy and carotid IMT or a high carotid plaque score in the CRF patient groups. No consistent association was found between elevated tHcy and coronary artery disease, cerebrovascular disease or peripheral arterial disease. Renal function, described as creatinine clearance, was the strongest determinant for tHcy level. Significant predictors of carotid atherosclerosis were age, duration of hypertension and elevated low-density lipoprotein cholesterol level. In conclusion, the present study shows no apparent association between tHcy level and atheromatous carotid findings in patients with CRF. However, because of the changing renal function in the course of renal disease, the strong confounding effect of renal function may not be adequately controlled for the analysis of the significance of elevated tHcy level for CVD in patients with CRF. Copyright 2004 Elsevier Ireland Ltd

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262188     DOI: 10.1016/j.atherosclerosis.2004.04.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.

Authors:  Halil Tanriverdi; Harun Evrengul; Hatice Mergen; Ceren Acar; Deniz Seleci; Omur Kuru; Seyhan Tanriverdi; Asuman Kaftan
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

2.  Homocystein and carotid atherosclerosis in chronic renal failure.

Authors:  M Lubomirova; A Tzoncheva; J Petrova; B Kiperova
Journal:  Hippokratia       Date:  2007-10       Impact factor: 0.471

3.  Prognostic Significance of Abnormal Ankle-Brachial Index Among Long-term Hemodialysis Patients in Kinshasa, the Democratic Republic of the Congo.

Authors:  Yannick Mompango Engole; François Bompeka Lepira; Yannick Mayamba Nlandu; Yves Simbi Lubenga; Clarisse Nkondi; Augustin Luzayadio Longo; Aliocha Nkodila; Jean-Robert Rissassy Makulo; Vieux Momeme Mokoli; Justine Busanga Bukabau; Marie France Ingole Mboliasa; Evariste Mukendi Kadima; Cedric Kabemba Ilunga; Chantal Vuvu Zinga; Nazaire Mangani Nseka; Ernest Kiswaya Sumaili
Journal:  Rambam Maimonides Med J       Date:  2021-01-19

4.  Darbepoetin alpha reduces oxidative stress and chronic inflammation in atherosclerotic lesions of apo E deficient mice in experimental renal failure.

Authors:  Nicole Arend; Karl F Hilgers; Valentina Campean; Britta Karpe; Nada Cordasic; Bernd Klanke; Kerstin Amann
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.